Stroke prevention in patients with atrial fibrillation (AF) is one pillar of the management of
this common arrhythmia. Substantial advances in the epidemiology and associated …

Abstract Background The PRAGUE-17 (Left Atrial Appendage Closure vs Novel
Anticoagulation Agents in Atrial Fibrillation) trial demonstrated that left atrial appendage …

Left atrial appendage closure is an alternative to chronic oral anticoagulation to prevent
embolic events related to nonvalvular atrial fibrillation. After device implantation …

Background: No study has so far compared Amulet with the new Watchman FLX in terms of
residual left atrial appendage (LAA) patency or clinical outcomes in patients undergoing …

Objectives This study sought to investigate clinical outcomes associated with left atrial
appendage occlusion (LAAO) versus direct oral anticoagulants (DOACs) in patients with …

Background: Left atrial appendage closure is an established therapy in patients with atrial
fibrillation. Although device-related thrombosis (DRT) is relatively rare, it is potentially linked …

Introduction and objectives This article presents the annual activity report of the
Interventional Cardiology Association of the Spanish Society of Cardiology (ACI-SEC) for the …

Introducción y objetivos La Asociación de Cardiología Intervencionista de la Sociedad
Española de Cardiología (ACI-SEC) presenta su informe anual de actividad de 2019 …

Abstract Background Data on Device-related Thrombus (DRT) after left atrial appendage
closure (LAAC) remain scarce. This study aimed to investigate risk factors for DRT from …

Percutaneous left atrial appendage closure (LAAC) has become an important non-
pharmacological intervention for stroke prevention in patients with non-valvular atrial …